LEI: 549300BNS685UXH4JI75
31 December 2020 (the 2020 Annual Report ). Hard copy versions of the following documents will be sent to those shareholders who have elected to receive paper communication: · 2020 Annual Report · 2021 Notice of Annual General Meeting Shareholders who have not elected to receive paper communication will be sent communications notifying them of the availability of these documents on the Company s website. Shareholders are encouraged to vote electronically at www.hikmashares.com . Accordingly, the Company has not produced a paper form of proxy. Should shareholders wish to use a paper proxy, the registrars will provide one upon request (Link Market Services, 10th Floor, Central Square, 29 Wellington Street, Leeds LS1 4DL, United Kingdom, Tel: 0871 664 0300 (from within the UK) or +44 371 664 0300 (from outside the UK), E-mail: [email protected])
Investegate |Hikma Pharmaceutical Announcements | Hikma Pharmaceutical: Director/PDMR Shareholding investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.